Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Friedrich-Alexander Universität Erlangen-Nürnberg neurotensin receptor 1 (NTSR1) compound 6b
- Development stage
- Unknown
- Lead developer
- Friedrich-Alexander University Erlangen Nuremberg
- Modality
- Peptides
01
Overview
Friedrich-Alexander Universität Erlangen-Nürnberg neurotensin receptor 1 (NTSR1) compound 6b: sourced facts only. name: "The newly developed NT(8-13) analog 6b incorporating an S-functionalized homocysteine revealed covalent binding of the neurotensin receptor 1 (NTSR1) in a radioligand depletion study." [PMID:35334449]; target: "The newly developed NT(8-13) analog 6b incorporating an S-functionalized homocysteine revealed covalent binding of the neurotensin receptor 1 (NTSR1) in a radioligand depletion study." [PMID:35334449]; developer: "Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Straße 10, D-91058 Erlangen, Germany." [PMID:35334449]; modality: "The newly developed NT(8-13) analog 6b incorporating an S-functionalized homocysteine revealed covalent binding of the neurotensin receptor 1 (NTSR1) in a radioligand depletion study." [PMID:35334449]
Beyond the preview
Go deeper on Friedrich-Alexander Universität Erlangen-Nürnberg neurotensin receptor 1 (NTSR1) compound 6b.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Friedrich-Alexander Universität Erlangen-Nürnberg neurotensin receptor 1 (NTSR1) compound 6b.